CDC Vaccine Panel Faces Delays and Debates on COVID-19 and Hepatitis B Shots
TL;DR Summary
The CDC's vaccine advisory panel (ACIP) is discussing and voting on various COVID-19 vaccine recommendations, including changes to hepatitis B vaccination timing and the process of decision-making, amid debates over transparency and scientific evidence, with recent appointments of new members including vaccine critics and allies.
- Watch Live: CDC advisory panel discusses COVID-19 vaccine risks, spars with outside experts over process CBS News
- 'We are rookies': Day 2 of CDC vaccine meeting opens with a reversal and a surprise NPR
- CDC hepatitis B vaccine vote delayed: What parents should know about possible changes ABC News - Breaking News, Latest News and Videos
- In chaotic start to meeting, CDC vaccine advisers delay hepatitis B vaccine vote, cast new MMRV vaccine vote CNN
- RFK Jr.’s Vaccine Committee to Vote on Hepatitis B and Covid Shots The New York Times
Reading Insights
Total Reads
1
Unique Readers
1
Time Saved
10 min
vs 11 min read
Condensed
98%
2,105 → 45 words
Want the full story? Read the original article
Read on CBS News